Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer
Abhishek Bharadwaj Sharma1, Muhammad Khairul Ramlee1, Joel Kosmin1
1Department of Biochemistry, University of Oxford, South Parks Road, Oxford, UK.
Researchers found C16orf72 is crucial for repairing DNA replication stress and works with PARP1/2. This discovery reveals a new pathway that helps cells resist PARP inhibitors, impacting cancer therapy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The synthetic lethality of PARP inhibitors (PARP1/PARP2) in homologous recombination (HR)-deficient cells is known.
- However, other synthetic lethal interactions with PARP1/PARP2 disruption remain unclear.
Purpose of the Study:
- To identify novel genes synthetically lethal with PARP1/2 disruption.
- To elucidate the mechanisms underlying these interactions and their role in genome stability and drug resistance.
Main Methods:
- Conducted a genome-wide screen to identify genes synthetic lethal with PARP1/2 disruption.
- Investigated the function of identified genes, specifically C16orf72, in response to replication stress.
- Analyzed the interaction of C16orf72 with other proteins like BRCA1 and Senataxin.
Main Results:
- Identified C16orf72 (also known as HAPSTR1/TAPR1) as a novel modulator of replication-associated R-loops.
- C16orf72 is essential for replication fork restart, DNA damage suppression, and genome stability under replication stress.
- C16orf72 and PARP1/2 act in parallel pathways to reduce DNA:RNA hybrids at stalled replication forks.
- C16orf72 interacts with BRCA1 and Senataxin to facilitate their recruitment to RNA:DNA hybrids, conferring PARP inhibitor resistance.
Conclusions:
- Discovered a C16orf72/Senataxin/BRCA1-dependent pathway that suppresses R-loop accumulation during replication.
- This pathway is critical for maintaining genome stability and confers resistance to PARP inhibitors.
- Highlights C16orf72 as a potential therapeutic target in cancer treatment.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
Telomeres and Telomerase
Long-patch Base Excision Repair
Homologous Recombination
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

